EUVIMEDOpdag EUVIMED
Klinische StudieOpen access

Efficacy of an Electronic Cognitive Behavioral Therapy Program Delivered via the Online Psychotherapy Tool for Depression and Anxiety Related to the COVID-19 Pandemic: Pre-Post Pilot Study

Elnaz Moghimi iD, Callum Stephenson iD, Anika Agarwal iD, Niloofar Nikjoo iD, Niloufar Malakouti iD, Gina Layzell iD, Anne O'Riordan iD, Jasleen Jagayat iD, Amirhossein Shirazi iD, Gilmar Gutierrez iD, Ferwa Khan iD, Charmy Patel iD and 3 more

JMIR Mental Health · 2023

DOI: 10.2196/51102 ↗

At a glance

Klinische Studie in JMIR Mental Health, 2023. Written by Elnaz Moghimi and 14 co-authors. Institution: Department of Psychiatry, Faculty of Health Sciences, Queen's University, Kingston, ON, Canada. Major MEDLINE topics: Cognitive Behavioral Therapy, COVID-19, Major Depressive Disorder, Mindfulness. Cited 12 times so far (Crossref); 48 references. The full text is freely available in PubMed Central.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Lockdowns and social distancing resulting from the COVID-19 pandemic have worsened the population’s mental health and made it more difficult for individuals to receive care. Electronic cognitive behavioral therapy (e-CBT) is a cost-effective and evidence-based treatment for anxiety and depression and can be accessed remotely.

Objective

The objective of the study was to investigate the efficacy of online psychotherapy tailored to depression and anxiety symptoms during the pandemic.

Methods

The pilot study used a pre-post design to evaluate the efficacy of a 9-week e-CBT program designed for individuals with depression and anxiety affected by the pandemic. Participants were adults (N=59) diagnosed with major depressive disorder and generalized anxiety disorder, whose mental health symptoms initiated or worsened during the COVID-19 pandemic. The online psychotherapy program focused on teaching coping, mindfulness, and problem-solving skills. Symptoms of anxiety and depression, resilience, and quality of life were assessed.

Results

Participants demonstrated significant improvements in symptoms of anxiety (P=.02) and depression (P=.03) after the intervention. Similar trends were observed in the intention-to-treat analysis. No significant differences were observed in resilience and quality-of-life measures. The sample comprised mostly females, making it challenging to discern the benefits of the intervention in males. Although a pre-post design is less rigorous than a controlled trial, this design was selected to observe changes in scores during a critical period. Conclusions e-CBT for COVID-19 is an effective and accessible treatment option. Improvements in clinical symptoms of anxiety and depression can be observed in individuals whose mental health is affected by the COVID-19 pandemic. Trial Registration ClinicalTrials.gov NCT04476667; https://clinicaltrials.gov/study/NCT04476667 International Registered Report Identifier (IRRID) RR2-10.2196/24913

Subjects

MeSH terms (MEDLINE)

Cognitive Behavioral TherapyCOVID-19Major Depressive DisorderMindfulnessAdultFemaleHumansMaleAnxietyAnxiety DisordersCommunicable Disease ControlDepressionPandemicsPilot ProjectsQuality of Life

Author keywords

COVID-19anxietycognitive behavioral therapydepressionefficacyelectronic cognitive behavioral therapyevidence-based treatmentmental healthonlineonline psychotherapy toolpandemic

Authors and institutions

  • Department of Psychiatry, Faculty of Health Sciences, Queen's University, Kingston, ON, Canada.
  • School of Rehabilitation Therapy, Queen's University, Kingston, ON, Canada.
  • Centre for Neuroscience Studies, Queen's University, Kingston, ON, Canada.
  • Patient and Family Centered Care, Kingston Health Sciences Centre, Kingston, ON, Canada.
  • OPTT Inc, Toronto, ON, Canada.

ORCID profiles: Elnaz Moghimi, Callum Stephenson, Anika Agarwal, Niloofar Nikjoo, Niloufar Malakouti, Gina Layzell, Anne O'Riordan, Jasleen Jagayat, Amirhossein Shirazi, Gilmar Gutierrez, Ferwa Khan, Charmy Patel, Megan Yang, Mohsen Omrani, Nazanin Alavi

Cite

APA

Moghimi, E., Stephenson, C., Agarwal, A., Nikjoo, N., Malakouti, N., Layzell, G., O'Riordan, A., Jagayat, J., Shirazi, A., Gutierrez, G., Khan, F., Patel, C., Yang, M., Omrani, M., & Alavi, N. (2023). Efficacy of an Electronic Cognitive Behavioral Therapy Program Delivered via the Online Psychotherapy Tool for Depression and Anxiety Related to the COVID-19 Pandemic: Pre-Post Pilot Study. JMIR Mental Health. https://doi.org/10.2196/51102

Vancouver

Moghimi E, Stephenson C, Agarwal A, Nikjoo N, Malakouti N, Layzell G, et al. Efficacy of an Electronic Cognitive Behavioral Therapy Program Delivered via the Online Psychotherapy Tool for Depression and Anxiety Related to the COVID-19 Pandemic: Pre-Post Pilot Study. JMIR Mental Health. 2023. doi:10.2196/51102

BibTeX
@article{Moghimi2023,
  author = {Moghimi, Elnaz and Stephenson, Callum and Agarwal, Anika and Nikjoo, Niloofar and Malakouti, Niloufar and Layzell, Gina and O'Riordan, Anne and Jagayat, Jasleen and Shirazi, Amirhossein and Gutierrez, Gilmar and Khan, Ferwa and Patel, Charmy and Yang, Megan and Omrani, Mohsen and Alavi, Nazanin},
  title = {Efficacy of an Electronic Cognitive Behavioral Therapy Program Delivered via the Online Psychotherapy Tool for Depression and Anxiety Related to the COVID-19 Pandemic: Pre-Post Pilot Study},
  journal = {JMIR Mental Health},
  year = {2023},
  doi = {10.2196/51102}
}
Start for free →